Rapid on-site testing FastDetect delivers rapid, multi-person, on-site diagnostic testing across pathogens, presenting a compelling value proposition for healthcare providers seeking quick results to streamline patient flow and reduce wait times.

Patentable tech moat With 15 patents tied to the FastDetect SmartTest, the company has a defensible technology platform that can be leveraged for upsell into adjacent pathogen panels and long-term contracts with labs and clinics seeking reliable, differentiated diagnostics.

Focused healthcare partnerships The team’s credibility from Caltech and JPL connections, combined with a track record in infectious disease response, positions FastDetect well for partnerships with hospitals, urgent care networks, and government health programs seeking rapid deployment diagnostics.

Growth through expansion As the company develops newer versions to cover additional pathogens, there is an opportunity to scale through tiered product offerings, phased deployments, and service contracts that align with expanding market demand for point-of-care testing.

SMB to mid-market potential With revenue in the low-to-mid millions and a small team, FastDetect can target mid-market clinics and regional lab networks that require scalable, cost-effective rapid testing solutions, complementing larger enterprise suppliers with a faster, more flexible option.